NTRA Natera Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: NTRA

Price (delayed)

$102.65

Market cap

$12.61B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.12

Enterprise value

$12.22B

Naterais a pioneer and global leader in cell-free DNA testing from a simple blood draw. The mission of the company is to change the management of disease worldwide with a ...

Highlights
Natera's gross profit has surged by 66% YoY and by 23% QoQ
The EPS has increased by 42% YoY and by 17% from the previous quarter
Sector: Healthcare
Industry: Diagnostics & Research
Peers: PRTA VRTX ARDX EBS

Key stats

What are the main financial stats of NTRA
Market
Shares outstanding
122.8M
Market cap
$12.61B
Enterprise value
$12.22B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
15.61
Price to sales (P/S)
10.26
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
10.11
Earnings
Revenue
$1.21B
EBIT
-$352.22M
EBITDA
-$311.83M
Free cash flow
-$186.98M
Per share
EPS
-$3.12
Free cash flow per share
-$1.55
Book value per share
$6.58
Revenue per share
$10
TBVPS
$12.15
Balance sheet
Total assets
$1.47B
Total liabilities
$674.09M
Debt
$427.83M
Equity
$794.11M
Working capital
$955.5M
Liquidity
Debt to equity
0.54
Current ratio
4.12
Quick ratio
3.83
Net debt/EBITDA
1.24
Margins
EBITDA margin
-25.8%
Gross margin
50.3%
Net margin
-30.2%
Operating margin
-31.6%
Efficiency
Return on assets
-26.1%
Return on equity
-49.7%
Return on invested capital
-38.7%
Return on capital employed
-30.3%
Return on sales
-29.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NTRA stock price

How has the Natera stock price performed over time
Intraday
0.49%
1 week
-3.14%
1 month
-7.85%
1 year
117.85%
YTD
63.87%
QTD
-5.21%

Financial performance

How have Natera's revenue and profit performed over time
Revenue
$1.21B
Gross profit
$607.71M
Operating income
-$382.26M
Net income
-$365.46M
Gross margin
50.3%
Net margin
-30.2%
Natera's gross profit has surged by 66% YoY and by 23% QoQ
The company's net margin has surged by 52% YoY and by 25% QoQ
NTRA's operating margin is up by 49% year-on-year and by 23% since the previous quarter
NTRA's revenue is up by 39% year-on-year and by 12% since the previous quarter

Growth

What is Natera's growth rate over time

Valuation

What is Natera stock price valuation
P/E
N/A
P/B
15.61
P/S
10.26
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
10.11
The EPS has increased by 42% YoY and by 17% from the previous quarter
The stock's P/B is 57% more than its last 4 quarters average of 9.9 and 17% more than its 5-year quarterly average of 13.3
NTRA's equity is up by 22% year-on-year and by 3.8% since the previous quarter
NTRA's price to sales (P/S) is 52% higher than its last 4 quarters average of 6.7
NTRA's revenue is up by 39% year-on-year and by 12% since the previous quarter

Efficiency

How efficient is Natera business performance
The ROS has soared by 53% YoY and by 25% from the previous quarter
The ROE has soared by 51% YoY and by 20% from the previous quarter
The ROA is up by 43% year-on-year and by 18% since the previous quarter
The return on invested capital has increased by 22% year-on-year and by 10% since the previous quarter

Dividends

What is NTRA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NTRA.

Financial health

How did Natera financials performed over time
NTRA's total assets is 118% higher than its total liabilities
NTRA's total assets is up by 11% YoY
The current ratio is up by 6% year-on-year
The company's debt is 46% lower than its equity
NTRA's equity is up by 22% year-on-year and by 3.8% since the previous quarter
The debt to equity has contracted by 19% YoY and by 3.6% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.